Zydus Lifesciences Limited has informed the Exchange regarding Change in Director(s) of the company.
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Zydus Lifesciences announced two board changes at its May 19, 2026 meeting. First, it re-appointed Dr. Sharvil P. Patel as Managing Director for another 5-year term starting April 1, 2027, subject to shareholder approval at the AGM. Dr. Sharvil is the son of Chairman Pankaj R. Patel and has been leading the company, which is known for its pharma products like Sugar Free and Glucon D. Second, it appointed Mr. Kulin S. Lalbhai as an Additional and Independent Director for 5 years effective May 19, 2026. Mr. Lalbhai brings digital and consumer business expertise from his current role as Whole Time Director at Arvind Limited. Both appointments require shareholder approval.
The re-appointment of Dr. Sharvil Patel provides continuity in leadership and is positive for stability. The addition of Mr. Kulin Lalbhai as an Independent Director strengthens board independence and brings fresh external expertise in digital and consumer businesses.